Difference between revisions of "Profiles"

From QIBA Wiki
Jump to: navigation, search
(See Also)
 
(109 intermediate revisions by 4 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
Profiles published here have completed one of the '''[[QIBA Profile Stages]]''' of development and been approved by their [[Committees|Biomarker Committee]].
+
Profiles published here have completed one of the '''[[QIBA Profile Stages]]''' of development and been approved by their [[Committees|Biomarker Committee]]
 +
 
 +
Profiles '''[[How to use QIBA Profiles|may be of use]]''' at any Stage.
  
 
===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles===
 
===[[QIBA_Profile_Stages#Stage_3:_Technically_Confirmed|Stage 3]]: Technically Confirmed Profiles===
 +
 +
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
 +
:* Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
 +
:* Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
 +
 
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
 
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
:* [[Media:UPICT Oncologic FDG-PETCTProtocol Dec-2014a.pdf|UPICT Protocol - Oncology FDG-PET CT v2.0 Dec-2014]]
+
:* [[Media:UPICT Oncologic FDG-PETCTProtocol Dec-2014a.pdf|UPICT Protocol - Oncology FDG-PET CT v2.0 2014-12]]
 +
 
  
 
===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles===
 
===[[QIBA_Profile_Stages#Stage_2:_Consensus|Stage 2]]: Consensus Profiles===
  
*[[Media:MRE-QIBAProfile-2018-05-02-CONSENSUS.pdf | MR Elastography of the Liver 2018-05-02]]  
+
* [[Media:QIBA_DWIProfile_Consensus_Dec2019_Final.pdf|Diffusion-Weighted Magnetic Resonance Imaging (DWI) 2019-12-20]]
  
* [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.02.11.docx|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-02-11]]
+
* [[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]]
  
*[[Media:001.QIBA_SPECT_Ioflupane Profile.v1.1 post-public comments.clean copy.2017 06 26.pdf | SPECT Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease v1.1 2017-06-26]]
+
*[[Media:QIBA_AmyloidPET_20June2018_consensus.pdf | 18F-labeled PET tracers targeting Amyloid as an Imaging Biomarker 2018-06-20]]  
  
:*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|Checklist - SPECT Profile Conformance]]
+
*[[Media:MRE-QIBA_Profile-2019-06-06-CONSENSUS-maintenance.pdf | MR Elastography of the Liver 2019-06-06]]  
  
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_Consensus-20161121b.pdf| CT Tumor Volumetry for Advanced Disease 2016-11-21b]]  
+
*[[Media:001.QIBA_SPECT_Ioflupane Profile.v1.1 post-public comments.clean copy.2017 06 26.pdf | SPECT Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease v1.1, 2017-06-26]]
 +
 
 +
*[[Media:002.QIBA SPECT Ioflupane Profile v2.0.2019 10 15.pdf | SPECT Quantifying Dopamine Transporters with 123 - Iodine Labeled Ioflupane in Neurodegenerative Disease v2.0, 2019-10-15]]
 +
 
 +
:*[[Media:002.QIBA SPECT Profile Checklist Extract.2016 10 31.docx|Checklist - SPECT Profile Conformance]]
  
:* [[Media:QIBA_CVol_TumorVolumeChangeChecklist-20161205_-_Field_Test_version_1.0.docx| Checklist - CT Tumor Volumetry for Advanced Disease]]
 
 
 
*[[Media:DCE-MRI Quantification Profile v1.0.pdf|MR DCE Quantification v1.0 2012-08-08]]
 
*[[Media:DCE-MRI Quantification Profile v1.0.pdf|MR DCE Quantification v1.0 2012-08-08]]
 +
  
 
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles===
 
===[[QIBA_Profile_Stages#Stage_1:_Public_Comment|Stage 1]]: Public Comment Profiles===
  
Submit comments using the online form: ''' http://tinyurl.com/QIBA-Public-Comment-Form '''
+
'''Please submit comments using the '''[http://tinyurl.com/QIBA-Public-Comment-Form '''online form''']'''
<br \><font size="2" color="FireBrick">(Note: each form accommodates 10 comments; submit additional forms as necessary)</font>
+
*[[Media:QIBA_SPECT_99mTC_Profile_10.21.19.pdf|SPECT-CT: Estimating the Concentration of 99mTc Based Imaging Biomarkers in Large and Small Volumes of Interest Profile 2019-10-21]] (<font color=green>'''Public Comment Open''': November 1, 2019 - February 3, 2020<font>)
  
* ''There are currently no Profiles open for Public Comment''  
+
*[[Media:QIBA_US_SWS_Profile_10.21.19.pdf|QIBA US Measurement of Shear Wave Speed for Estimation of Liver Fibrosis Profile 2019-10-21]] ('''closed''' on December 18, 2019)
  
 +
:*[[Media:SWS Checklists-Appendix E.xlsx|Appendix E: QIBA US SWS Checklists for Implementation of the SWS Profile, 2019-10-21]] ('''closed''' on December 18, 2019)
  
Public Comment '''closed''' for the following Profiles (comment resolution is underway on the corresponding committee page):
+
*[[Media:QIBA_CT_Lung_Density_Profile_090319-clean.pdf | QIBA CT Lung Density Profile 2019-09-03]] (Contains Conformance Checklist, Appendix B) ('''closed''' on October 16, 2019)
*[[Media:QIBA_fMRI_Profile_1_PC-rev1.pdf| fMRI 2017-06-19]] (''Closed on December 31, 2017'')
+
 
*[[Media:QIBA_PET Amyloid_Profile_15June2017-post-public-comment.pdf | PET Amyloid: 18F-labeled PET Tracers Targeting Amyloid as an Imaging Biomarker - 2018-05-02]] (''Closed on September 15, 2017'')  
+
:*[[Media:QIBA CT Lung Density Protocols-Appendix D.xlsx|QIBA CT Lung Density Protocols-Appendix D, 2019-06-26]] ('''closed''' on October 16, 2019)
*[[Media:Draft-MRE-QIBAProfile-2017-07-28_clean.pdf| MR Elastography 2017-08-15]] (''Closed on September 15, 2017'')  
+
 
*[[Media:QIBADWIProfilev1.45_20170427_v5_accepted_linenumbers.pdf| MR DWI 2017-04-27]] (''Closed on August 25, 2017'')
+
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]] ('''closed''' on April 5th, 2019)
 +
 
 +
*[[Media:QIBA_CTA_Profile_as_of_2019-Feb-29.pdf| Atherosclerosis Biomarkers by (C)CTA - 2019 Imaging Profile 2019-02-26]] ('''closed''' on June 3rd, 2019)
 +
 
 +
 
 +
'''[[Comment Resolutions]]''' <font color=black>are posted for '''Past Public Comments''' and '''Past Technical Confirmations'''.<font>
  
  
Line 45: Line 62:
  
 
: QIBA SPECT Biomarker Committee.  Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance.  Version 1.1.  Profile Stage: Consensus.  QIBA, June 30, 2017.  Available from: http://qibawiki.rsna.org/index.php/Profiles
 
: QIBA SPECT Biomarker Committee.  Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance.  Version 1.1.  Profile Stage: Consensus.  QIBA, June 30, 2017.  Available from: http://qibawiki.rsna.org/index.php/Profiles
 +
  
 
==Statements of Endorsement==
 
==Statements of Endorsement==

Latest revision as of 17:29, 14 January 2020

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Profiles may be of use at any Stage.

Stage 3: Technically Confirmed Profiles

  • Conformance Checklists (refer to Appendix C in the Profile document - pg 42)
  • Assessment Procedures (refer to Section 4 in the Profile document - pg 30)


Stage 2: Consensus Profiles


Stage 1: Public Comment Profiles

Please submit comments using the online form


Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.


Format for Citing Profiles

Cite QIBA Profile documents as:

Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. QIBA, Date. Available from: URL

Example:

QIBA SPECT Biomarker Committee. Quantifying Dopamine Transporters with 123Iodine Labeled Ioflupane in Neurodegenerative Diseases, Quantitative Imaging Biomarkers Alliance. Version 1.1. Profile Stage: Consensus. QIBA, June 30, 2017. Available from: http://qibawiki.rsna.org/index.php/Profiles


Statements of Endorsement


See Also